TRIN 📈 Trinity Capital - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8964423086
TRIN: Venture Debt, Equipment Financing, Term Loans, Equity Investments
Trinity Capital Inc. is a business development company. It is a venture capital firm specializing in growth capital, innovative medical devices, venture debt to growth stage companies looking for loans and/or equipment financing, generate current income and, to a lesser extent, capital appreciation through investments, including term loans and equity-related investments. Trinity Capital Inc. was founded in 2019 is based in Phoenix, Arizona with additional offices in the United States. Web URL: https://www.trinitycap.com
Additional Sources for TRIN Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TRIN Stock Overview
| Market Cap in USD | 856m |
| Sector | Financial Services |
| Industry | Asset Management |
| GiC Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2021-01-29 |
TRIN Stock Ratings
| Growth 5y | 63.7% |
| Fundamental | 4.92% |
| Dividend | 86.7% |
| Rel. Strength Industry | -64.9 |
| Analysts | 4.5/5 |
| Fair Price Momentum | 16.13 USD |
| Fair Price DCF | - |
TRIN Dividends
| Dividend Yield 12m | 13.72% |
| Yield on Cost 5y | 22.33% |
| Annual Growth 5y | 17.42% |
| Payout Consistency | 95.8% |
TRIN Growth Ratios
| Growth Correlation 3m | 82.5% |
| Growth Correlation 12m | 70.6% |
| Growth Correlation 5y | 78.7% |
| CAGR 5y | 13.25% |
| CAGR/Mean DD 5y | 1.29 |
| Sharpe Ratio 12m | 0.49 |
| Alpha | -10.31 |
| Beta | 0.76 |
| Volatility | 17.75% |
| Current Volume | 361.8k |
| Average Volume 20d | 552.8k |
What is the price of TRIN stocks?
As of December 26, 2024, the stock is trading at USD 14.80 with a total of 361,830 shares traded.
Over the past week, the price has changed by +3.50%, over one month by +3.86%, over three months by +10.52% and over the past year by +11.50%.
As of December 26, 2024, the stock is trading at USD 14.80 with a total of 361,830 shares traded.
Over the past week, the price has changed by +3.50%, over one month by +3.86%, over three months by +10.52% and over the past year by +11.50%.
Is Trinity Capital a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Trinity Capital is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.92 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRIN as of December 2024 is 16.13. This means that TRIN is currently overvalued and has a potential downside of 8.99%.
Neither. Based on ValueRay Fundamental Analyses, Trinity Capital is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.92 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRIN as of December 2024 is 16.13. This means that TRIN is currently overvalued and has a potential downside of 8.99%.
Is TRIN a buy, sell or hold?
Trinity Capital has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy TRIN.
Trinity Capital has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy TRIN.
- Strong Buy: 6
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for TRIN stock price target?
According to ValueRays Forecast Model, TRIN Trinity Capital will be worth about 18 in December 2025. The stock is currently trading at 14.80. This means that the stock has a potential upside of +21.82%.
According to ValueRays Forecast Model, TRIN Trinity Capital will be worth about 18 in December 2025. The stock is currently trading at 14.80. This means that the stock has a potential upside of +21.82%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 15.6 | 5.3% |
| Analysts Target Price | 15.6 | 5.1% |
| ValueRay Target Price | 18 | 21.8% |